GSK revises US Avandia label to include new restrictions on use

Links shared publicly online about this topic.

523
total visits

GSK revises US Avandia label to include new restrictions on use

GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia®, Avandamet® and Avandaryl®) to include additional safety information and restrictions on the use of these medicines.

View full resource at gsk.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Drug, Avandia, GlaxoSmithKline, Safety, Medical

Most Recently Shared on February 8, 2011 at 1:50 am By:

Hope Warshaw

RT @Diabetes_Type2: GSK revises US Avandia label to include new restrictions on use: GSK today announced revised U... http://bit.ly/ihJcNE

1 year ago...

Retweet

Favorite

Also Shared By:

Diabetes, Type 2

GSK revises US Avandia label to include new restrictions on use

gsk.com — “GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia®, Avandamet® and Avandaryl®) to include additional safety information and restrictions on the use of these medicines.” View full resource at gsk.com